FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293224517> ?p ?o ?g. }

• W4293224517 endingPage "18" @default.
• W4293224517 startingPage "1" @default.
• W4293224517 abstract "Objective. Dingkun Pill (DKP) is a proprietary Chinese medicine that has been utilized for patients with gynecological diseases, and its clinical application has been widely accepted in China. However, the effects of DKP on reproduction and metabolism in women with polycystic ovary syndrome (PCOS) have never been systematically evaluated. Our objective was to evaluate the efficacy and safety of DKP in treating reproductive and metabolic abnormalities with PCOS. Methods. We searched in PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, VIP Database, and Chinese Biomedical Literature Database up until January 2022 to identify randomized controlled trials (RCTs). The methodological quality of the included RCTs was estimated using the Cochrane collaboration risk-of-bias instrument, and the meta-analysis was performed using RevMan. Results. A total of 22 RCTs (including 1994 participants) were identified. DKP, combined with ovulation-inducing drugs (OID) or combined oral contraceptives (COC) was superior to OID or COC alone in improving the pregnancy rate (relative risk (RR) 1.84, 95% CI 1.62 to 2.11 and RR 1.38, 95% CI 1.16 to 1.64, respectively), ovulation rate (RR 1.38, 95% CI 1.03 to 1.84 and RR 1.23, 95% CI 1.11 to 1.37, respectively), endometrial thickness (weighted mean difference (WMD) 2.50, 95% CI 1.91 to 3.09 and WMD 0.62, 95% CI 0.08 to 1.16, respectively), luteinizing hormone (WMD −1.93, 95% CI −2.80 to−.07 and WMD −1.79, 95% CI −2.66 to−0.92, respectively), and testosterone (standardized mean difference (SMD) −2.12, 95% CI −3.01 to−1.24 and SMD −1.21, 95% CI −1.64 to−0.78, respectively). DKP combined with COC led to a greater improvement in homeostasis model assessment-β (WMD 20.42, 95% CI 16.85 to 23.98) when compared with COC alone. There was a significant difference between DKP and COC in terms of decreasing total cholesterol (WMD −0.37, 95% CI −0.72 to−0.02), triacylglycerol (WMD −0.85, 95% CI −1.50 to−0.20), and free fatty acid (WMD −130.00, 95% CI −217.56 to−42.22). However, DKP did not affect the follicle stimulating hormone, fasting blood glucose, fasting insulin, body mass index, waist-to-hip ratio, high-density lipoprotein cholesterol, or low-density lipoprotein cholesterol. Adverse reactions were more common in COC alone compared to DKP and COC in combination (RR 0.22, 95% CI 0.07 to 0.63). Conclusion. DKP shows promise in modifying reproductive and metabolic parameters in patients with PCOS and may be used as a primary choice in conventional or complementary therapies for PCOS. The quality of the evidence analyzed was suboptimal, and therefore, our results should be interpreted cautiously. More prospective large-scale and well-designed RCTs, as well as longer intervention durations are required in the future to draw more reliable conclusions." @default.
• W4293224517 created "2022-08-27" @default.
• W4293224517 creator A5002827089 @default.
• W4293224517 creator A5009223452 @default.
• W4293224517 creator A5019303133 @default.
• W4293224517 creator A5026946284 @default.
• W4293224517 creator A5028357567 @default.
• W4293224517 creator A5033974059 @default.
• W4293224517 creator A5080133467 @default.
• W4293224517 creator A5082681437 @default.
• W4293224517 date "2022-08-24" @default.
• W4293224517 modified "2023-10-18" @default.
• W4293224517 title "The Efficacy and Safety of Dingkun Pill in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" @default.
• W4293224517 cites W1970586482 @default.
• W4293224517 cites W2021923144 @default.
• W4293224517 cites W2049014963 @default.
• W4293224517 cites W2049252045 @default.
• W4293224517 cites W2057987456 @default.
• W4293224517 cites W2099232726 @default.
• W4293224517 cites W2117559317 @default.
• W4293224517 cites W2124481954 @default.
• W4293224517 cites W2125672663 @default.
• W4293224517 cites W2156098321 @default.
• W4293224517 cites W2156993772 @default.
• W4293224517 cites W2159377764 @default.
• W4293224517 cites W2165010366 @default.
• W4293224517 cites W2186218348 @default.
• W4293224517 cites W2359158807 @default.
• W4293224517 cites W2460154883 @default.
• W4293224517 cites W2468996569 @default.
• W4293224517 cites W2515092587 @default.
• W4293224517 cites W2581259529 @default.
• W4293224517 cites W2588106564 @default.
• W4293224517 cites W2752750580 @default.
• W4293224517 cites W2799415441 @default.
• W4293224517 cites W2854044000 @default.
• W4293224517 cites W2884536266 @default.
• W4293224517 cites W2927077480 @default.
• W4293224517 cites W2953784146 @default.
• W4293224517 cites W2954998422 @default.
• W4293224517 cites W2972235025 @default.
• W4293224517 cites W2973122616 @default.
• W4293224517 cites W2978795816 @default.
• W4293224517 cites W2980849864 @default.
• W4293224517 cites W2987017313 @default.
• W4293224517 cites W2991056594 @default.
• W4293224517 cites W3025760896 @default.
• W4293224517 cites W3034173398 @default.
• W4293224517 cites W3041550542 @default.
• W4293224517 cites W3086364943 @default.
• W4293224517 cites W3114360973 @default.
• W4293224517 cites W3144062976 @default.
• W4293224517 cites W3174149868 @default.
• W4293224517 cites W3175213800 @default.
• W4293224517 cites W3199422888 @default.
• W4293224517 cites W4251646064 @default.
• W4293224517 doi "https://doi.org/10.1155/2022/8698755" @default.
• W4293224517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36062168" @default.
• W4293224517 hasPublicationYear "2022" @default.
• W4293224517 type Work @default.
• W4293224517 citedByCount "0" @default.
• W4293224517 crossrefType "journal-article" @default.
• W4293224517 hasAuthorship W4293224517A5002827089 @default.
• W4293224517 hasAuthorship W4293224517A5009223452 @default.
• W4293224517 hasAuthorship W4293224517A5019303133 @default.
• W4293224517 hasAuthorship W4293224517A5026946284 @default.
• W4293224517 hasAuthorship W4293224517A5028357567 @default.
• W4293224517 hasAuthorship W4293224517A5033974059 @default.
• W4293224517 hasAuthorship W4293224517A5080133467 @default.
• W4293224517 hasAuthorship W4293224517A5082681437 @default.
• W4293224517 hasBestOaLocation W42932245171 @default.
• W4293224517 hasConcept C126322002 @default.
• W4293224517 hasConcept C131872663 @default.
• W4293224517 hasConcept C168563851 @default.
• W4293224517 hasConcept C2776478404 @default.
• W4293224517 hasConcept C2776537878 @default.
• W4293224517 hasConcept C2777391703 @default.
• W4293224517 hasConcept C2777702977 @default.
• W4293224517 hasConcept C2779234561 @default.
• W4293224517 hasConcept C2779306644 @default.
• W4293224517 hasConcept C29456083 @default.
• W4293224517 hasConcept C3018442814 @default.
• W4293224517 hasConcept C44249647 @default.
• W4293224517 hasConcept C54355233 @default.
• W4293224517 hasConcept C71315377 @default.
• W4293224517 hasConcept C71924100 @default.
• W4293224517 hasConcept C81603835 @default.
• W4293224517 hasConcept C82789193 @default.
• W4293224517 hasConcept C86803240 @default.
• W4293224517 hasConcept C95190672 @default.
• W4293224517 hasConcept C98274493 @default.
• W4293224517 hasConceptScore W4293224517C126322002 @default.
• W4293224517 hasConceptScore W4293224517C131872663 @default.
• W4293224517 hasConceptScore W4293224517C168563851 @default.
• W4293224517 hasConceptScore W4293224517C2776478404 @default.
• W4293224517 hasConceptScore W4293224517C2776537878 @default.
• W4293224517 hasConceptScore W4293224517C2777391703 @default.
• W4293224517 hasConceptScore W4293224517C2777702977 @default.

• next